vs
Side-by-side financial comparison of FIRST MID BANCSHARES, INC. (FMBH) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
FIRST MID BANCSHARES, INC. is the larger business by last-quarter revenue ($88.2M vs $83.1M, roughly 1.1× PROCEPT BioRobotics Corp). FIRST MID BANCSHARES, INC. runs the higher net margin — 26.8% vs -38.1%, a 64.9% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 3.4%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 5.0%).
First Mid Bancshares Inc. is a U.S.-headquartered regional financial services holding company. It provides full-range retail and commercial banking products, wealth management, insurance solutions, and agricultural financing, mainly serving individual consumers, small and medium-sized enterprises, and agricultural clients across multiple Midwestern states including Illinois, Missouri, and Indiana.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
FMBH vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $88.2M | $83.1M |
| Net Profit | $23.7M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 34.0% | -4.1% |
| Net Margin | 26.8% | -38.1% |
| Revenue YoY | 3.4% | 20.2% |
| Net Profit YoY | 23.5% | -27.9% |
| EPS (diluted) | $0.98 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $88.2M | $76.4M | ||
| Q3 25 | $89.3M | $83.3M | ||
| Q2 25 | $87.5M | $79.2M | ||
| Q1 25 | $84.3M | $69.2M | ||
| Q4 24 | $85.3M | $68.2M | ||
| Q3 24 | $80.6M | $58.4M | ||
| Q2 24 | $79.2M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $23.7M | $-29.8M | ||
| Q3 25 | $22.5M | $-21.4M | ||
| Q2 25 | $23.4M | $-19.6M | ||
| Q1 25 | $22.2M | $-24.7M | ||
| Q4 24 | $19.2M | $-18.9M | ||
| Q3 24 | $19.5M | $-21.0M | ||
| Q2 24 | $19.7M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 34.0% | -40.6% | ||
| Q3 25 | 32.2% | -27.8% | ||
| Q2 25 | 34.4% | -28.0% | ||
| Q1 25 | 33.4% | -39.7% | ||
| Q4 24 | 29.7% | -28.9% | ||
| Q3 24 | 31.5% | -38.4% | ||
| Q2 24 | 33.7% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 26.8% | -39.1% | ||
| Q3 25 | 25.2% | -25.7% | ||
| Q2 25 | 26.8% | -24.7% | ||
| Q1 25 | 26.3% | -35.8% | ||
| Q4 24 | 22.5% | -27.6% | ||
| Q3 24 | 24.2% | -35.9% | ||
| Q2 24 | 24.9% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.98 | $-0.54 | ||
| Q3 25 | $0.94 | $-0.38 | ||
| Q2 25 | $0.98 | $-0.35 | ||
| Q1 25 | $0.93 | $-0.45 | ||
| Q4 24 | $0.81 | $-0.34 | ||
| Q3 24 | $0.81 | $-0.40 | ||
| Q2 24 | $0.82 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.6M |
| Total DebtLower is stronger | $354.5M | $51.7M |
| Stockholders' EquityBook value | $958.7M | $347.7M |
| Total Assets | $8.0B | $487.1M |
| Debt / EquityLower = less leverage | 0.37× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $354.5M | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $958.7M | $365.9M | ||
| Q3 25 | $932.2M | $380.3M | ||
| Q2 25 | $894.1M | $385.8M | ||
| Q1 25 | $870.9M | $389.2M | ||
| Q4 24 | $846.4M | $402.2M | ||
| Q3 24 | $858.5M | $241.2M | ||
| Q2 24 | $813.6M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $8.0B | $508.1M | ||
| Q3 25 | $7.8B | $511.5M | ||
| Q2 25 | $7.7B | $513.1M | ||
| Q1 25 | $7.6B | $519.4M | ||
| Q4 24 | $7.5B | $534.0M | ||
| Q3 24 | $7.6B | $374.1M | ||
| Q2 24 | $7.6B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.37× | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $130.9M | — |
| Free Cash FlowOCF − Capex | $124.0M | — |
| FCF MarginFCF / Revenue | 140.6% | — |
| Capex IntensityCapex / Revenue | 7.8% | — |
| Cash ConversionOCF / Net Profit | 5.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | $207.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $130.9M | $-10.3M | ||
| Q3 25 | $33.0M | $-6.6M | ||
| Q2 25 | $7.7M | $-15.0M | ||
| Q1 25 | $47.9M | $-17.0M | ||
| Q4 24 | $124.4M | $-32.4M | ||
| Q3 24 | $33.1M | $-18.8M | ||
| Q2 24 | $24.0M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $124.0M | $-12.2M | ||
| Q3 25 | $31.9M | $-9.5M | ||
| Q2 25 | $6.0M | $-17.8M | ||
| Q1 25 | $46.0M | $-18.8M | ||
| Q4 24 | $119.5M | $-33.6M | ||
| Q3 24 | $32.0M | $-19.0M | ||
| Q2 24 | $22.9M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 140.6% | -15.9% | ||
| Q3 25 | 35.8% | -11.4% | ||
| Q2 25 | 6.8% | -22.5% | ||
| Q1 25 | 54.5% | -27.2% | ||
| Q4 24 | 140.0% | -49.2% | ||
| Q3 24 | 39.7% | -32.6% | ||
| Q2 24 | 28.9% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 7.8% | 2.4% | ||
| Q3 25 | 1.2% | 3.4% | ||
| Q2 25 | 2.0% | 3.5% | ||
| Q1 25 | 2.3% | 2.7% | ||
| Q4 24 | 5.8% | 1.7% | ||
| Q3 24 | 1.4% | 0.4% | ||
| Q2 24 | 1.4% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 5.53× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 2.16× | — | ||
| Q4 24 | 6.49× | — | ||
| Q3 24 | 1.70× | — | ||
| Q2 24 | 1.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FMBH
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
